|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 4 (February 15), 2000:
pp. 1249-1257
Targeted disruption of Stat6 DNA binding activity by an
oligonucleotide decoy blocks IL-4-driven TH2 cell response
Li Hua Wang,
Xiao Yi Yang,
Robert A. Kirken,
James H. Resau, and
William L. Farrar
From the Cytokine Molecular Mechanisms Section, Laboratory of
Molecular Immunoregulation, Division of Basic Sciences; the Intramural
Research Support Program, SAIC Frederick, National Cancer
Institute-Frederick Cancer Research and Development Center, Frederick,
MD; the Department of Integrative Biology, Pharmacology, and
Physiology, University of Texas at Houston, TX; and the ABL-Basic
Research Program, National Cancer Institute, Frederick, MD.
The transcription factor, signal transducer and activator of
transcription (Stat) 6, regulates TH2-lymphocyte activity
by controlling the expression and responsiveness to interleukin
(IL)-4, which plays a key role in numerous allergic maladies.
Therefore, we sought to use a phosphorothiolate cis-element decoy to
target disruption of Stat6 transcriptional activity. Here we showed
that the Stat6 decoy potently ablated the messenger RNA expression and
production of IL-4, but not of several other cytokines.
The Stat6 decoy functionally disrupted IL-4-inducible
cell proliferation of murine TH2 cells and primary human
CD4+ T lymphocytes. Specificity of the decoy was
demonstrated by its ability to directly block Stat6 binding to a
cis-element probe and transactivation, but not affect Stat6 tyrosine
phosphorylation or expression of the IL-4 receptor chains. Moreover,
the decoy failed to inhibit non-Stat6-dependent signaling pathways
since IL-2 was competent to induce cell proliferation and activation of
Stats 1, 3, and 5a/b. With the use of laser scanning confocal microscopy, fluorescently tagged Stat6 decoy was detectable in the
cytoplasm and nucleus; however, greater levels of oligonucleotide were
present in the latter following IL-4 treatment. Taken together, these
data suggest that IL-4-driven TH2 cell activity can be
preferentially restricted via targeted disruption of Stat6 by a novel
and specific decoy strategy that may possess gene therapeutic potential.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. R. Hoffmann, C. Jourdan-Le Saux, F. W. Hoffmann, P. S. Chang, O. Bollt, Q. He, E. K. Tam, and M. J. Berry
A Role for Dietary Selenium and Selenoproteins in Allergic Airway Inflammation
J. Immunol.,
September 1, 2007;
179(5):
3258 - 3267.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyazaki, T. Satoh, K. Nishioka, and H. Yokozeki
STAT-6-Mediated Control of P-Selectin by Substance P and Interleukin-4 in Human Dermal Endothelial Cells
Am. J. Pathol.,
August 1, 2006;
169(2):
697 - 707.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Taha, Q. Hamid, L. Cameron, and R. Olivenstein
T Helper Type 2 Cytokine Receptors and Associated Transcription Factors GATA-3, c-MAF, and Signal Transducer and Activator of Transcription Factor-6 in Induced Sputum of Atopic Asthmatic Patients
Chest,
June 1, 2003;
123(6):
2074 - 2082.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Wang, X. Y. Yang, X. Zhang, K. Mihalic, W. Xiao, and W. L. Farrar
The cis Decoy against the Estrogen Response Element Suppresses Breast Cancer Cells via Target Disrupting c-fos not Mitogen-activated Protein Kinase Activity
Cancer Res.,
May 1, 2003;
63(9):
2046 - 2051.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler
Signal transducer and activator of transcription proteins in leukemias
Blood,
April 15, 2003;
101(8):
2940 - 2954.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. Leong, G. A. Andrews, D. E. Johnson, K. F. Dyer, S. Xi, J. C. Mai, P. D. Robbins, S. Gadiparthi, N. A. Burke, S. F. Watkins, et al.
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth
PNAS,
April 1, 2003;
100(7):
4138 - 4143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev.,
March 1, 2003;
55(1):
133 - 166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Litterst and E. Pfitzner
An LXXLL Motif in the Transactivation Domain of STAT6 Mediates Recruitment of NCoA-1/SRC-1
J. Biol. Chem.,
September 20, 2002;
277(39):
36052 - 36060.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. von Knethen and B. Brune
Activation of Peroxisome Proliferator-Activated Receptor {gamma} by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst
J. Immunol.,
September 1, 2002;
169(5):
2619 - 2626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. F. Skinnider, A. J. Elia, R. D. Gascoyne, B. Patterson, L. Trumper, U. Kapp, and T. W. Mak
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
Blood,
January 15, 2002;
99(2):
618 - 626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.C. Kips, K.G. Tournoy, and R.A. Pauwels
New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5
Eur. Respir. J.,
March 1, 2001;
17(3):
499 - 506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. VON KNETHEN and B. BRUNE
Delayed activation of PPAR{gamma} by LPS and IFN-{gamma} attenuates the oxidative burst in macrophages
FASEB J,
February 1, 2001;
15(2):
535 - 544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. McKay, F. Botelho, P. J. M. Ceponis, and C. D. Richards
Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability
Am J Physiol Gastrointest Liver Physiol,
November 1, 2000;
279(5):
G1094 - G1103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. M. Ceponis, F. Botelho, C. D. Richards, and D. M. McKay
Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway. LACK OF EVIDENCE FOR STAT 6 INVOLVEMENT
J. Biol. Chem.,
September 8, 2000;
275(37):
29132 - 29137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. Wang, X. Y. Yang, K. Mihalic, W. Xiao, D. Li, and W. L. Farrar
Activation of Estrogen Receptor Blocks Interleukin-6-inducible Cell Growth of Human Multiple Myeloma Involving Molecular Cross-talk between Estrogen Receptor and STAT3 Mediated by Co-regulator PIAS3
J. Biol. Chem.,
August 17, 2001;
276(34):
31839 - 31844.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
